e-learning
resources
Breathe
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
Lydia J. Finney
Source:
Breathe, 15 (2) 137; 10.1183/20734735.0015-2019
Journal Issue:
June
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lydia J. Finney. Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?. Breathe, 15 (2) 137; 10.1183/20734735.0015-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
The role of bronchodilator treatment in the prevention of exacerbations of COPD
Source: Eur Respir J 2012; 40: 1545-1554
Year: 2012
Comparison of the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Is it effective to administer corticosteroids late for neonatal chronic lung disease?
Source: Eur Respir J 2004; 24: Suppl. 48, 620s
Year: 2004
Patients with underuse and overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhalation medication
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness
Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016
Year: 2017
Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations
Source: Eur Respir Rev 2006; 15: 47-51
Year: 2006
Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
Predicting physician decision to prescribe systemic corticosteroids following an exacerbation of airways disease
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Opioid use, perhaps a harbinger of worsening COPD?
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Are bronchodilator drugs really useful in COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 94s
Year: 2001
Is the coprescription of Beta-blockers and Beta2-agonists justified in patients with coexisting COPD and CHF?
Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
Year: 2009
Reducing cholinergic constriction: the major reversible mechanism in COPD
Source: Eur Respir Rev 2006; 15: 32-36
Year: 2006
Utility of palliative treatment of dyspnoea with epidural methadone in patients with advanced emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 58s
Year: 2001
Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
Source: ERJ Open Res, 6 (3) 00093-2020; 10.1183/23120541.00093-2020
Year: 2020
Roflumilast with long-acting ?2-agonists for COPD: influence of exacerbation history
Source: Eur Respir J 2011; 38: 553-560
Year: 2011
Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005
Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
Modern treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 60S-66S
Year: 2001
Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept